Comparison between young and old patients with bronchogenic carcinoma
Affiliations
Affiliations
- Department of Medicine, Kuwait University, Safat. nasser_beh@hsc.kuniv.edu.kw
Abstract
The aim of this study was to compare the clinical characteristics, histological type, stage at diagnosis, treatment and survival of young (< or = 45 years) and older patients with bronchogenic carcinoma. The study was designed as a retrospective review of all lung cancer patients referred to the Kuwait Cancer Control Center over a 10-year period from 1985 to 1994. The study comprised 590 patients with primary bronchogenic carcinoma, of whom 72 (12%) were < or = 45 years of age at the time of diagnosis. Median (range) duration of symptoms, percentage of smokers and male to female ratios for the younger and older patients were 8 (2-48) weeks vs. 8 (1-52) weeks (p = 0.9), 74% vs. 83% (p = 0.06) and 5.5 vs. 5.3, respectively. The majority of patients had advanced stage disease at presentation; 91% of the younger patients had stage III or IV compared with 88% of the older patients (p = 0.1). The histological types for the younger and older patients were 32% vs. 20% for adenocarcinoma (p = 0.01) and 33% vs. 45% for squamous cell carcinoma (p = 0.1). There were more patients in the younger group who had surgery (21% vs. 7.5%) than in the older group (p = 0.001). Follow-up data were available for 177 patients out of 190 Kuwaiti national patients (93%). The median (range) survival rates for young and old patients were 8 (3-62) months and 7 (1-174) months, respectively (p = 0.09). Only 6 patients survived for more than 5 years, one (7.6%) from the younger group and 5 (3%) from the older group. Our study shows a relatively high percentage of young patients in our population of lung cancer patients. Apart from the higher incidence of adenocarcinoma in the young group and the fact that these patients had more surgery than the older group, there were no other significant differences between the two groups.
Similar articles
Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program.
Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, Kalemkerian GP.Chest. 1999 May;115(5):1232-6. doi: 10.1378/chest.115.5.1232.PMID: 10334132
Bronchogenic carcinoma in patients age 30 and younger.
Whooley BP, Urschel JD, Antkowiak JG, Takita H.Ann Thorac Cardiovasc Surg. 2000 Apr;6(2):86-8.PMID: 10870000
Surgical treatment of primary lung cancer in patients less than 40 years of age.
Shimono T, Hayashi T, Kimura M, Yada I, Namikawa S, Yuasa H, Kusagawa M.J Clin Oncol. 1994 May;12(5):981-5. doi: 10.1200/JCO.1994.12.5.981.PMID: 8164051
Age does not influence early and late tumor-related outcome for bronchogenic carcinoma.
Bernet F, Brodbeck R, Guenin MO, Schüpfer G, Habicht JM, Stulz PM, Carrel TP.Ann Thorac Surg. 2000 Mar;69(3):913-8. doi: 10.1016/s0003-4975(99)01439-3.PMID: 10750783 Review.
Moro D, Nagy-Mignotte H, Bolla M, Colonna M, Brichon PY, Brambilla C, Schaerer R, Vrousos C.Bull Cancer. 1997 Feb;84(2):155-61.PMID: 9180838 Review. French.
Cited by
Reddy R, Reddy S.Med Princ Pract. 2022;31(5):480-485. doi: 10.1159/000527246. Epub 2022 Oct 4.PMID: 36195060 Free PMC article.
Joobeur S, Ben Saad A, Migaou A, Fahem N, Mhamed SC, Rouatbi N.Pan Afr Med J. 2020 Jan 23;35:19. doi: 10.11604/pamj.2020.35.19.21100. eCollection 2020.PMID: 32341740 Free PMC article. French.
Zhong W, Zhao J, Huang K, Zhang J, Chen Z.Int J Clin Exp Pathol. 2018 Feb 1;11(2):1031-1035. eCollection 2018.PMID: 31938198 Free PMC article.
Bronchogenic carcinoma in patients under 50 years old.
Blanco M, García-Fontán E, Rivo JE, Repáaz JR, Obeso GA, Cañizares MA.Clin Transl Oncol. 2009 May;11(5):322-5. doi: 10.1007/s12094-009-0361-7.PMID: 19451066
Adams J, White M, Forman D.J Epidemiol Community Health. 2005 Feb;59(2):146-51. doi: 10.1136/jech.2004.021006.PMID: 15650147 Free PMC article.